ArticleBMC plant biology2026
Plant-derived N, S-Co-doped carbon dots enable reductive engineering of Ag-Fe bimetallic nanocomposites with broad-spectrum bioactivity.
Article in BMC plant biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
N, S-co-doped carbon dots (N, S-CDs) were synthesized from Calotropis gigantea leaves via a green hydrothermal method and used as dual-function reducing and stabilizing agents for the in situ fabrication of Ag-Fe bimetallic nanocomposites (Ag-Fe@N, S-CDs). Thus, this study presents a sustainable nanoplatform that combines heteroatom-doped carbon dots with bimetallic systems without the use of external chemical reducing agents. The N, S-CDs exhibited effective antioxidant activity with IC₅₀ values of 39.17 µg mL⁻¹ (DPPH), 42.26 µg mL⁻¹ (FRAP), and 15.30 µg mL⁻¹ (ABTS). In contrast, Ag-Fe@N, S-CDs showed improved anti-inflammatory activity with albumin denaturation inhibition of 59.48-77.38% and proteinase inhibition up to 93.63%, along with enhanced cytotoxicity against MCF-7 cells (IC₅₀ = 90.15 µg mL⁻¹). Both nanomaterials exhibited effective antimicrobial activity with minimum inhibitory concentration (MIC) values ranging from 31.25 to 250 µg mL⁻¹ against tested pathogens. These results indicate that N, S-CDs are more effective as antioxidant agents due to their rich surface functional groups, whereas Ag-Fe@N, S-CDs show superior anti-inflammatory and cytotoxic performance due to synergistic interactions between the metal components and the carbon framework. Therefore, the present study revealed a green and efficient strategy for designing multifunctional nanocomposites with potential biomedical applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.